Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
BioVentrix logo

BioVentrix

+1
医疗器械22 employeesFounded 2003🇺🇸 美国
总部
🇺🇸120 Forbes Blvd, Mansfield, Massachusetts 02048, Us (+1)
行业
医疗器械
员工人数
22
成立年份
2003
排名
#1,792,666

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

专长
医疗器械制药行业医疗保健

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 BioVentrix 的市场扩张

全球扩张

实时
最近 90 天
阶段
探索中0投入中0拓展中0规模化中0
近期动态
推进中30天
新增90天

活动脉搏

最近 90 天内有 2 个信号。

最近 90 天
招聘
0
无活动
营销与公关
0
无活动
产品与技术
2↓ 已结束
云端足迹
+2个类别已锁定
已显示 5 个中的 3 个
了解一下

关于 BioVentrix 的常见问题

关于 BioVentrix 的业务、市场和增长信号的快速解答。

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

800M+
监测企业
50+
本地数据来源
16
动向信号
每日
更新频率
“企业进入市场的那一周,我们就触达他们——而不是一个季度之后。”
增长负责人 · Pubrio 上一支 500+ 人的营收团队

洞察全球企业的每一步动向。

与我们的团队预约一次动向地图导览。

pubrio

Pubrio 把横跨 200+ 个市场的扩张信号整合为一张实时图谱,让营收团队看见哪些公司正进军新市场,并把握时机。

关注

向 AI 了解 Pubrio

面向 AI 智能体

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio。保留所有权利。